ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,592.39
      -0.74%
      US Tech 100
      19,878.80
      -1.19%
      Dow Jones
      39,771.33
      0.13%
      Brent Oil
      85.065
      0.02%
      Bitcoin
      58,024.43
      0.46%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Okyo Pharma Limited (OKYO)

      7. Okyo Pharma Limited (OKYO) News

      OKYO

      Okyo Pharma (OKYO)

      Okyo Pharma Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:OKYO
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      05/18/20225:10AMUK RegulatoryOKYO Pharma Limited Director/PDMR ShareholdingLSE:OKYOOkyo Pharma Limited
      05/17/202210:04AMUK RegulatoryOKYO Pharma Limited OKYO Announces Pricing of IPO of ADSs in the U.S.LSE:OKYOOkyo Pharma Limited
      05/17/20222:01AMUK RegulatoryOKYO Pharma Limited OKYO Announces Pricing of IPO of ADSs in the U.S.LSE:OKYOOkyo Pharma Limited
      04/27/20222:02AMRNS Non-RegulatoryOKYO Pharma Limited Upcoming Presentations at Ophthalmic ConferenceLSE:OKYOOkyo Pharma Limited
      03/07/20222:01AMUK RegulatoryOKYO Pharma Limited Additional ListingLSE:OKYOOkyo Pharma Limited
      02/23/20223:11PMAlliance NewsAlliance NewsTRADING UPDATES: BiVictriX expands development; Okyo wins US patentLSE:OKYOOkyo Pharma Limited
      02/23/20222:00AMUK RegulatoryOKYO Pharma Limited Patent issued: to treat ocular neuropathic painLSE:OKYOOkyo Pharma Limited
      02/21/202212:00PMUK RegulatoryOKYO Pharma Limited CLN Conversion, exercise of Warrants, equity issueLSE:OKYOOkyo Pharma Limited
      02/15/20225:16PMAlliance NewsAlliance NewsTRADING UPDATES: Tullow faces Norway charge; Light Science wins grantLSE:OKYOOkyo Pharma Limited
      02/15/20224:12AMDow Jones NewsOKYO Pharma Has US FDA Meeting on Dry-Eye-Disease TreatmentLSE:OKYOOkyo Pharma Limited
      02/15/20222:00AMUK RegulatoryOKYO Pharma Limited Successful Pre-IND Meeting with the FDA on OK-101LSE:OKYOOkyo Pharma Limited
      02/01/20221:59AMUK RegulatoryOKYO Pharma Limited Director/PDMR ShareholdingLSE:OKYOOkyo Pharma Limited
      01/27/20222:00AMUK RegulatoryOKYO Pharma Limited Director/PDMR ShareholdingLSE:OKYOOkyo Pharma Limited
      01/26/20223:18PMAlliance NewsAlliance NewsTRADING UPDATES: Somero upbeat after strong year; Scancell in profitLSE:OKYOOkyo Pharma Limited
      01/26/20229:05AMUK RegulatoryOKYO Pharma Limited Second Price Monitoring ExtnLSE:OKYOOkyo Pharma Limited
      01/26/20229:00AMUK RegulatoryOKYO Pharma Limited Price Monitoring ExtensionLSE:OKYOOkyo Pharma Limited
      01/26/20222:00AMUK RegulatoryOKYO Pharma Limited Half-year ReportLSE:OKYOOkyo Pharma Limited
      12/14/20215:01PMAlliance NewsAlliance NewsIN BRIEF: Okyo Pharma receives patent by US Patent & Trademark OfficeLSE:OKYOOkyo Pharma Limited
      12/14/20211:59AMUK RegulatoryOKYO Pharma Limited U.S. Patent issued for use of OK-101 to treat DEDLSE:OKYOOkyo Pharma Limited
      12/13/20212:00AMUK RegulatoryOKYO Pharma Limited OK-101:Anti-inflammatory & Pain-Reducing PotentialLSE:OKYOOkyo Pharma Limited
      12/07/202110:11AMAlliance NewsAlliance NewsIN BRIEF: Okyo Pharma plans to file new drug application in 2022LSE:OKYOOkyo Pharma Limited
      12/06/20212:18PMAlliance NewsAlliance NewsTRADING UPDATES: Great Western notes good assays; Guild signs VillalbaLSE:OKYOOkyo Pharma Limited
      12/06/20212:00AMUK RegulatoryOKYO Pharma Limited IND filing Q3 2022 and Phase 2 initiation Q4 2022LSE:OKYOOkyo Pharma Limited
      12/01/202110:59AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chairLSE:OKYOOkyo Pharma Limited
      12/01/20212:00AMUK RegulatoryOKYO Pharma Limited Directorate ChangeLSE:OKYOOkyo Pharma Limited
      10/19/202111:41AMUK RegulatoryOKYO Pharma Limited Second Price Monitoring ExtnLSE:OKYOOkyo Pharma Limited
      10/19/202111:35AMUK RegulatoryOKYO Pharma Limited Price Monitoring ExtensionLSE:OKYOOkyo Pharma Limited
      10/19/20219:05AMUK RegulatoryOKYO Pharma Limited Second Price Monitoring ExtnLSE:OKYOOkyo Pharma Limited
      10/19/20219:00AMUK RegulatoryOKYO Pharma Limited Price Monitoring ExtensionLSE:OKYOOkyo Pharma Limited
       Showing the most relevant articles for your search:LSE:OKYO